Tenders
Hormonal drug tenders in Czechia
Hormonal drug tenders in Czechia: 219 listed on GranTender since 2024. The median awarded contract value is about €82,000 (132 contracts with a stated value). Buyers with the most tenders: Fakultní nemocnice Olomouc (37), Fakultní nemocnice Ostrava (25) and Institut klinické a experimentální medicíny (13); suppliers with the most contract awards: ViaPharma s.r.o. (11), Takeda Pharmaceuticals Czech Republic s.r.o. (10) and VIVAX Management (CZ), s.r.o. (7). Sources: Registr smluv, ISVZ (NIPEZ) and TED. In 2025 the median contract value was €100,000; 40% of contracts drew a single bid (2.5 bids on average). Data as of 18 November 2026; updated daily.
- Tenders
- 219
- Open tenders
- 0
- Awards
- 366
- Awarded value awarded
- €28,316,995
- Awarded value contract
- €50,100,571
- Awarded value framework ceiling
- €15,953,484
- Median contract value contract
- ≈ €97,000
- Median contract value awarded
- ≈ €82,000
- Median contract value framework ceiling
- ≈ €97,000
- Average bids per contract
- 2.3
- Tenders in 2025
- 91 +90% on 2024
Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.
Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.
Open tenders
No records yet.
Latest tenders
| Tender | Buyer | Estimated value | Status | Published |
|---|---|---|---|---|
| Léčivé přípravky s obsahem injekčních forem glukokortikoidů 2026 | Fakultní nemocnice Hradec Králové | CZK 14,406,400 (≈ €592,954) | Closed | 13 October 2026 |
| Léčivé přípravky s obsahem injekčních forem glukokortikoidů 2026 | Fakultní nemocnice Hradec Králové | CZK 14,406,400 (≈ €592,954) | Closed | 13 October 2026 |
| LP s obsahem relugolixu 2026 - sdružený nákup | Fakultní nemocnice Olomouc | CZK 9,656,817 (≈ €397,465) | Closed | 10 September 2026 |
| Kupní smlouva na vybavení pro kvantitativní analýzu hormonů - část b) | Česká zemědělská univerzita v Praze | — | Awarded | 9 September 2026 |
| DNS Výzva č. 102 H02AB04 - METHYLPREDNISOLON DEPOTNÍ | Městská nemocnice Ostrava, příspěvková organizace | — | Awarded | 24 August 2026 |
| DNS - Methylprednisolon II. | Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha | CZK 4,576,002 (≈ €188,344) | Cancelled | 4 August 2026 |
| DNS – Methylprednisolon-acetát (40 mg/ ml) II. | Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha | CZK 1,966,860 (≈ €80,954) | Cancelled | 4 August 2026 |
| Léčivé přípravky s obsahem solifenacinu | Fakultní nemocnice Hradec Králové | CZK 2,165,000 (≈ €89,109) | Awarded | 27 July 2026 |
| Léčivé přípravky s obsahem solifenacinu | Fakultní nemocnice Hradec Králové | CZK 2,165,000 (≈ €89,109) | Awarded | 27 July 2026 |
| Léčivé přípravky s obsahem solifenacinu | Fakultní nemocnice Hradec Králové | — | Awarded | 24 July 2026 |
| Léčivé přípravky s obsahem účinné látky Vazopresin (Argipresin) | Uherskohradišťská nemocnice a.s. | CZK 1,053,294 (≈ €43,353) | Awarded | 22 July 2026 |
| Léčivé přípravky s obsahem účinné látky Vazopresin (Argipresin) | Uherskohradišťská nemocnice a.s. | — | Awarded | 22 July 2026 |
| Léčivé přípravky s obsahem sodné soli levothyroxinu - VEŘEJNÁ LÉKÁRNA II | Fakultní nemocnice Hradec Králové | CZK 2,200,000 (≈ €90,550) | Awarded | 16 July 2026 |
| Léčivé přípravky s obsahem sodné soli levothyroxinu - VEŘEJNÁ LÉKÁRNA II | Fakultní nemocnice Hradec Králové | CZK 2,200,000 (≈ €90,550) | Awarded | 16 July 2026 |
| Léčivé přípravky s obsahem sodné soli levothyroxinu - VEŘEJNÁ LÉKÁRNA II | Fakultní nemocnice Hradec Králové | — | Awarded | 15 July 2026 |
| Kortikosteroidy pro systémové použití III. | Institut klinické a experimentální medicíny | CZK 4,778,000 (≈ €196,658) | Awarded | 15 July 2026 |
| DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ – Červenec_5/2026 - VOSORITID | Všeobecná fakultní nemocnice v Praze | — | Awarded | 15 July 2026 |
| DNS – Hydrokortison tbl | Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha | CZK 52,728 (≈ €2,170) | Cancelled | 2 July 2026 |
| DNS – Hydrokortison inj | Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha | CZK 1,303,212 (≈ €53,639) | Closed | 2 July 2026 |
| DNS – Terlipresin | Ústřední vojenská nemocnice - Vojenská fakultní nemocnice Praha | CZK 3,272,114 (≈ €134,677) | Closed | 2 July 2026 |
Top buyers
- Fakultní nemocnice Olomouc37
- Fakultní nemocnice Ostrava25
- Institut klinické a experimentální medicíny13
- Univerzita Palackého v Olomouci7
- Česká zemědělská univerzita v Praze6
- Krajská zdravotní, a.s.4
- Revmatologický ústav3
- Fakultní nemocnice Brno3
- Ústav experimentální botaniky AV ČR, v. v. i.3
- Městská nemocnice Ostrava, příspěvková organizace2
Top winners
Competition and prices
In 2025, half of the contracts were worth between €37,000 and €170,000, with a median of €100,000 (65 contracts with a stated awarded value). Contracts drew 2.5 bids on average (median 2) and 40% drew a single bid — based on 149 contracts with a known number of bids. Compared with 2024, in 2025 the median value rose 92% and the share of single-bid contracts fell from 47% to 40%. The usual procedures: open procedure (69%), other procedures (30%), restricted procedure (1%) — of 163 tenders with a stated procedure.
The most contracts went to ViaPharma s.r.o. (11), Takeda Pharmaceuticals Czech Republic s.r.o. (10) and VIVAX Management (CZ), s.r.o. (7) — together 8% of all contracts.
| Year | Contracts | Median value | Middle half of values | Bids on average | Single bid |
|---|---|---|---|---|---|
| 2024 | 87 | €52,000 | €26,000 – €110,000 | 1.7 | 47% (38) |
| 2025 | 167 | €100,000 | €37,000 – €170,000 | 2.5 | 40% (149) |
| 2026 (so far) | 105 | €69,000 (contract value) | €15,000 – €330,000 | 2.2 | 45% (85) |
| All years | 361 | €97,000 (contract value) | €23,000 – €310,000 | 2.3 | 43% (272) |
Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.
Where you have a chance
Since 1 November 2024, 42% of the 238 contracts with a known number of bids had a single bid; the median was 2 bids. The number of bids is known for 238 of the 278 contracts from procedures with competition.
Buyers who often get few offers
The buyers below usually received one or two offers per contract — an offer from you would stand out.
| Buyer | Contracts with known bids | Median bids | Single bid |
|---|---|---|---|
| Fakultní nemocnice Olomouc | 51 | 1 | 51% |
| Městská nemocnice Ostrava, příspěvková organizace | 47 | 2 | 34% |
| Fakultní nemocnice Ostrava | 12 | 2 | 42% |
In the last 12 months, 1 company won its first contract in our records here — 3% of the 37 contracts (our records start on 1 January 2024).
Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.
Main CPV divisions
CPV codes of this topic
A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.
Hormonal drugs and contraceptives in neighbouring countries
Today, 3 tenders in the same niche are open in neighbouring countries.
- Poland — 3 open today · how to bid in Poland
Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.
Market reports
Hormonal drugs and contraceptives by city
Hormonal drugs and contraceptives in other countries
Hormonal drugs and contraceptives across Europe
Topics in Health, medical equipment and medicines
Questions and answers
- Where can I find hormonal drug tenders in Czechia?
- GranTender lists them in one place, from Registr smluv, ISVZ (NIPEZ) and TED, with their buyers, winners and contract values. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
- Who wins the most hormonal drug tenders in Czechia?
- By number of contracts won: ViaPharma s.r.o. (11), Takeda Pharmaceuticals Czech Republic s.r.o. (10), VIVAX Management (CZ), s.r.o. (7).
- Which buyers publish the most hormonal drug tenders in Czechia?
- By number of tenders: Fakultní nemocnice Olomouc (37), Fakultní nemocnice Ostrava (25), Institut klinické a experimentální medicíny (13).
- Which CPV codes belong to “Hormonal drugs and contraceptives”?
- 33640000 Medicinal products for the genitourinary system and hormones; plus tenders without a usable CPV code whose title names the topic.
- How many bids do hormonal drug tenders in Czechia receive on average?
- In 2025, contracts drew 2.5 bids on average (median 2) and 40% drew a single bid — based on 149 contracts with a known number of bids.
- How much are contracts for hormonal drug tenders in Czechia worth?
- In 2025, half of the contracts were worth between €37,000 and €170,000, with a median of €100,000 (65 contracts with a stated awarded value). Compared with 2024, in 2025 the median value rose 92% and the share of single-bid contracts fell from 47% to 40%.
- Which procedures are used for hormonal drug tenders in Czechia?
- The usual procedures: open procedure (69%), other procedures (30%), restricted procedure (1%) — of 163 tenders with a stated procedure.
- Which buyers get few offers in hormonal drug tenders in Czechia?
- Since 1 November 2024, these buyers usually received one or two offers per contract: Fakultní nemocnice Olomouc (median 1 bid over 51 contracts), Městská nemocnice Ostrava, příspěvková organizace (median 2 bids over 47 contracts) and Fakultní nemocnice Ostrava (median 2 bids over 12 contracts). Since 1 November 2024, 42% of the 238 contracts with a known number of bids had a single bid; the median was 2 bids.
CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.